Keyphrases
Euglycemic
100%
Hyperinsulinemic Hypoglycemia
100%
Toxicological Effects
100%
Long-acting Insulin Analog
66%
Peripheral Nerve
66%
Brown Adipose Tissue
33%
Atrophy
33%
Transient Hyperglycemia
33%
Pancreatic Islets
33%
New Insulin
33%
Skeletal muscle
33%
Result Interpretation
33%
Hypoglycemia
33%
Muscle Changes
33%
Histopathological Changes
33%
Non-inferiority Trial
33%
Safety Self-efficacy
33%
Hyperphagia
33%
Regulatory Guidelines
33%
Skeletal muscle Tissue
33%
Weight Loss
33%
Unilocular
33%
Insulin Analogues
33%
Food Body
33%
Adipocyte
33%
Insulin Infusion
33%
Pharmacokinetic Profile
33%
Long Duration of Action
33%
Insulin
33%
Gluconeogenesis
33%
Patients with Diabetes
33%
Food Consumption
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoglycemia
100%
Toxicological Effect
100%
Insulin Analog
75%
Long Acting Insulin
50%
Clinical Study
25%
Antidiabetic Agent
25%
Preclinical Study
25%
Pharmacokinetic
25%
Hyperphagia
25%
Hyperglycemia
25%